Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,898 signal articles · 240 in last 24h · 118,599 total before filter · latest 55m ago
240last 24h
1537last 7d
255● bullish (7d)
158● bearish (7d)
205publishers
AllMacro292Earnings620M&A99Regulatory23Product13Analyst22
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Sanofi Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicines and cost discipline. The company also increased its 2030 sales ambition for Dupixent to approximately €25 billion while outlining an ongo

Teladoc Health Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Teladoc Health Q2 Earnings Call Highlights

Teladoc Health (NYSE:TDOC) reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at BetterHelp prompted the company to reduce its full-year revenue outlook. Consolidated